We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ZD:NASDAQZiff Davis, Inc. Analysis

Data as of 2026-09-19 - not real-time

$57.49

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

At $57.49, Ziff Davis, Inc. shows a bullish moving-average alignment, with shorter averages sitting above longer ones. Over a rolling month the price has gained 12.8%. RSI sits at 57.3, which reads as neutral, and MACD momentum is bullish. Watch $54.64 as support and $60.48 as the nearer resistance level.
Multiples put this in undervalued territory: 9.6 times earnings against the sector's 15.3. Consensus targets land 10.7% above where the shares trade now. Revenue is contracting at 2.7% on a 44.7% profit margin.
Risk comes out at 6 of a possible 10, a elevated reading. With 30-day volatility of 27.2%, a beta of 0.65 and a maximum drawdown of 33.8%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to buy, carrying 7/10 conviction.

Top Market Events

As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the digital media &...What a fantastic six months it’s been for Ziff Davis.Seeking Alpha1monZiff Davis: This Incredibly Cheap Cash Machine Is Hiding In Plain SightZiff Davis earns a 'strong buy'...

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 8/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 44.21
  • MACD momentum is positive

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 9.6 versus sector average of 15.3
  • Trading above the 200-day average of 44.21

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • P/E of 9.6 versus sector average of 15.3
  • Analyst targets imply +10.7% versus the current price
  • Negative return on equity of -1.5%

Key Metrics & Analysis

Financial Health

Revenue Growth-2.70%
Profit Margin44.75%
P/E Ratio9.6
ROE-1.46%
ROA3.09%
Debt/Equity39.98
P/B Ratio0.9
Op. Cash Flow$448.3M
Free Cash Flow$519.7M
Industry P/E15.3

Technical Analysis

TrendBullish
RSI57.3
Support$54.64
Resistance$60.48
MA 20$56.40
MA 50$54.65
MA 200$44.21
MACDBullish
VolumeIncreasing
Fear & Greed Index94.98

Valuation

Fair Value$208.32
Target Price$63.67
Upside/Downside10.74%
GradeUndervalued
TypeValue

Risk Assessment

Beta0.65
Volatility27.23%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.